The activation of Fas receptor by APO010, a recombinant form of Fas ligand, induces in vitro and in vivo antimyeloma activity

被引:0
|
作者
Ocio, Enrique M. [1 ,2 ]
Maiso, Patricia [2 ]
Garayoa, Meicedes [2 ]
Dupuis, Marc [3 ]
Pandiella, Atanasio [2 ]
Miguel, J. F. San [1 ,2 ]
机构
[1] Univ Hosp, Dept Hematol, Salamanca, Spain
[2] Univ Salamanca, Canc Res Ctr, Salamanca, Spain
[3] Apoxis SA, Lausanne, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1515
引用
收藏
页码:453A / 453A
页数:1
相关论文
共 23 条
  • [1] Characterization of resistance to APO010, a recombinant hexameric FAS ligand, in human myeloma cell lines.
    Jandu, Haatisha
    Nielsen, Annette
    Brunner, Nils
    Hansen, Anker
    Knudsen, Steen
    Jensen, Peter Buhl
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Characterization of resistance to a recombinant hexameric Fas-ligand (APO010) in human cancer cell lines
    Jandu, Haatisha
    Nielsen, Annette
    Brunner, Nils
    Hansen, Anker
    Knudsen, Steen
    Stenvang, Jan
    Jensen, Peter B.
    EXPERIMENTAL HEMATOLOGY, 2020, 87 : 33 - +
  • [3] APO010, a synthetic hexameric CD95 ligand, induces human glioma cell death in vitro and in vivo
    Eisele, Guenter
    Roth, Patrick
    Hasenbach, Kathy
    Aulwurm, Steffen
    Wolpert, Fabian
    Tabatabai, Ghazaleh
    Wick, Wolfgang
    Weller, Michael
    NEURO-ONCOLOGY, 2011, 13 (02) : 155 - 164
  • [4] Fas (APO-1) receptor Fas ligand expression in human gametes and pre-embryos in vitro
    Zaninovic, N
    Rimarachin, JA
    Veeck, LL
    Rosenwaks, Z
    HUMAN REPRODUCTION, 1997, 12 : O84 - O84
  • [5] IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions
    Kohara, Haruka
    Kitaura, Hideki
    Fujimura, Yuji
    Yoshimatsu, Masako
    Morita, Yukiko
    Eguchi, Toshiko
    Masuyama, Ritsuko
    Yoshida, Noriaki
    IMMUNOLOGY LETTERS, 2011, 137 (1-2) : 53 - 61
  • [6] Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway
    Nagai, H
    Kubo, M
    Abe, R
    Yamamoto, M
    Nohara, K
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2006, 6 (02) : 279 - 286
  • [7] The cardiac Fas (APO-1/CD95) receptor/Fas ligand system -: Relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes
    Wollert, KC
    Heineke, J
    Westermann, J
    Lüdde, M
    Fiedler, B
    Zierhut, W
    Laurent, D
    Bauer, MKA
    Schulze-Osthoff, K
    Drexler, H
    CIRCULATION, 2000, 101 (10) : 1172 - 1178
  • [8] Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo
    Ehl, S
    HoffmannRohrer, U
    Nagata, S
    Hengartner, H
    Zinkernagel, R
    JOURNAL OF IMMUNOLOGY, 1996, 156 (07): : 2357 - 2360
  • [9] Recombinant human G-CSF (rhuG-CSF) induces blockade of apoptosis via Fas receptor of peripheral blood neutrophils in vivo but not in vitro.
    Püllmann, K
    Stolze, B
    Kadar, J
    Baranova, K
    Stanulla, M
    Emmendörffer, A
    Welte, K
    BLOOD, 1998, 92 (10) : 179B - 179B
  • [10] Immunomodulating therapy with rIL-2 and interferon alpha induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (A pilot study)
    Demir, G
    Ozguroglu, M
    Sayhan, N
    Molinas-Mandel, N
    Demirelli, F
    Buyukunal, E
    Tuzuner, N
    Serdengecti, S
    Berkarda, B
    ANTICANCER RESEARCH, 1999, 19 (4C) : 3517 - 3520